Long-term immunologic response in HIV-infected patients with CD4 cell counts ≤50/mm3 when initiating protease inhibitor therapy.

被引：0

作者：

Le Moing, V

Eid, Z

Ecobichon, JL

Duval, X

Longuet, P

Elbim, C

Brun-Vezinet, F

Leport, C

Vilde, JL

机构：

[1] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, F-75877 Paris 18, France

[2] Hop Bichat Claude Bernard, Serv Immunohematol, F-75877 Paris, France

[3] Hop Bichat Claude Bernard, Serv Virol, F-75877 Paris 18, France

来源：

ANNALES DE MEDECINE INTERNE | 2001年 / 152卷 / 01期

关键词：

HIV infection; AIDS; protease inhibitors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

From March to July 1996, 61 patients with CD4 < 50/mm(3) began a therapy with protease inhibitors. Increase and maintenance of CD4 > 100/mm(3) was observed in 39/61 patients with a protective effect for occurrence of AIDS or death. This immunological response was correlated with the duration of the virological response. However, 38% of patients with long-term immunological response never had a undetectable viral Load.

引用

页码：11 / 14

页数：4